12/11/2024
8:01 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/11/2024
8:04 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/11/2024
7:58 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024
3:33 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/03/2024
3:38 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/02/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
12/02/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
|
11/27/2024
3:30 PM | Kazia Therapeutics (Filer)
| Form POS AM | |
11/27/2024
3:30 PM | Kazia Therapeutics (Filer)
| Form POS AM | |
11/06/2024
6:53 PM | Kazia Therapeutics (Subject)
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
| Form SC 13G | |
11/01/2024
3:05 PM | Kazia Therapeutics (Filer)
| Form NT 20-F | |
10/24/2024
7:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024
7:33 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024
7:38 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024
7:22 AM | Kazia Therapeutics (Filer)
| Form 6-K/A | |
10/15/2024
6:01 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
6:03 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/15/2024
6:04 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/15/2024
6:06 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024
3:52 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024
3:55 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024
3:57 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024
8:27 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024
8:23 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
8:25 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024
8:26 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024
8:06 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024
8:10 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024
8:12 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024
8:14 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/12/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
09/04/2024
7:56 PM | Kazia Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
08/12/2024
6:28 PM | Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2024
8:26 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024
8:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024
8:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024
8:19 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2024
4:29 PM | Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
| Form SC 13G | |
06/28/2024
3:27 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
06/24/2024
7:14 PM | Kazia Therapeutics (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
06/04/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad) You don’t actually want to buy Bitcoin this time around.
That’s because there’s a better way to take advantage of this new bull market…
One market expert calls it Crypto’s Hidden Gem
And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin…
That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky…
This is a much safer and better approach to ride this years’ crypto bull run.
Because believe it or not…
The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem |
05/29/2024
7:55 AM | Kazia Therapeutics (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
05/23/2024
6:00 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
6:03 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
05/01/2024
3:01 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/01/2024
3:06 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
04/19/2024
3:26 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
3:30 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/27/2024
7:37 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/27/2024
7:26 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
7:02 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
8:19 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
2:41 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kazia Therapeutics (Subject)
| Form SC 13G | |
02/12/2024
5:35 PM | Kazia Therapeutics (Subject)
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
| Form SC 13G | |
02/05/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
01/18/2024
3:30 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/12/2024
3:05 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/25/2023
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
